Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation from EMA's CHMP committee is based on a robust analytical, non-clinical and clinical data package comparing the biosimilar...
Hence then, the article about golimumab biosimilar gotenfia from stada and bio thera receives positive chmp opinion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion )
Also on site :
- MarketInk: After four decades with Padres and Chargers, Bill Johnston says authenticity & trust are key in any career
- After canceling Iran strikes, Trump says negotiations will resume Monday afternoon while Tehran continues Hormuz talks with Oman
- As AI creates more entrepreneurs and a skills mismatch, Gen Z faces the choice of being a specialist or a ‘general-purpose nerd’